VOYA Investment Management
ATYR

VOYA Investment Management’s aTyr Pharma ATYR Stock Holding History

VOYA Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.06K Sell
10,338
-6,256
-38% -$5.28K ﹤0.01% 2347
2025
Q4 		$13K Hold
16,594
– – ﹤0.01% 2408
2025
Q3 		$12K Sell
16,594
-8,018
-33% -$36.3K ﹤0.01% 2439
2025
Q2 		$125K Buy
+24,612
New +$96.8K ﹤0.01% 2438

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's ATYR Position: Q1 2026 in Review

VOYA Investment Management reduced its aTyr Pharma (ATYR) stake by 38% in Q1 2026, selling an estimated $5.28K and leaving 10,338 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

VOYA Investment Management first reported a position in ATYR in Q2 2025 and has held it in 4 quarters since. The position peaked at $125K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • VOYA Investment Management held 10,338 shares of aTyr Pharma worth $8.06K as of Q1 2026.
  • VOYA Investment Management sold 6,256 aTyr Pharma shares in Q1 2026, an estimated $5.28K.
  • aTyr Pharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2347 holding.
  • VOYA Investment Management first reported a position in aTyr Pharma in Q2 2025 and has held it in 4 quarters since.
  • VOYA Investment Management's aTyr Pharma position peaked at $125K in Q2 2025.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.